These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 322921)

  • 121. Synthetic and preliminary hemodynamic and whole animal toxicity studies on (R,S)-, (R)-, and (S)-2-methyl-3-(2,4,5-trihydroxyphenyl)alanine.
    Musson DG; Karashima D; Rubiero H; Melmon KL; Cheng A; Castagnoli N
    J Med Chem; 1980 Dec; 23(12):1318-23. PubMed ID: 7452683
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Negative Coombs tests in Chinese on methyldopa.
    Burns-Cox CJ
    Lancet; 1970 Sep; 2(7674):673-4. PubMed ID: 4195819
    [No Abstract]   [Full Text] [Related]  

  • 123. Mode of action of methyldopa.
    Day MD; Rand MJ
    J Pharm Pharmacol; 1967 Jun; 19(6):395-6. PubMed ID: 4382369
    [No Abstract]   [Full Text] [Related]  

  • 124. The antipyretic effect of alpha-methyldopa in experimental fever.
    van Miert AS; van Duin CT
    J Pharm Pharmacol; 1972 Dec; 24(12):988-90. PubMed ID: 4146534
    [No Abstract]   [Full Text] [Related]  

  • 125. The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.
    Struthers AD; Brown MJ; Adams EF; Dollery CT
    Br J Clin Pharmacol; 1985 Mar; 19(3):311-7. PubMed ID: 3986086
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Central nervous system mechanisms in blood pressure control.
    Struthers AD; Dollery CT
    Eur J Clin Pharmacol; 1985; 28 Suppl():3-11. PubMed ID: 2865146
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension.
    Planz G; Gierlichs HW; Hawlina A; Planz R; Stephany W; Rahn KH
    Eur J Clin Pharmacol; 1977 Dec; 12(4):241-5. PubMed ID: 338308
    [No Abstract]   [Full Text] [Related]  

  • 128. Site of action of methyldopa in lowering the blood pressure in man.
    Kersting F; Reid JL; Dollery CT
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():11-5. PubMed ID: 277299
    [TBL] [Abstract][Full Text] [Related]  

  • 129. The effects of desmethylimipramine on the pharmacological actions of alpha methyldopa in man.
    Reid JL; Porsius AJ; Zamboulis C; Polak G; Hamilton CA; Dean CR
    Eur J Clin Pharmacol; 1979 Sep; 16(2):75-80. PubMed ID: 499311
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Evidence for a predominantly central hypotensive effect of alpha-methyldopa in humans.
    Bobik A; Jennings G; Jackman G; Oddie C; Korner P
    Hypertension; 1986 Jan; 8(1):16-23. PubMed ID: 3943883
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.
    Pinder RM; Brogden RN; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 11(5):329-77. PubMed ID: 782834
    [No Abstract]   [Full Text] [Related]  

  • 132. Clinical and cardiovascular effects of alpha methyldopa in combination with decarboxylase inhibitors.
    Kersting F; Reid JL; Dollery CT
    Clin Pharmacol Ther; 1977 May; 21(5):547-55. PubMed ID: 322921
    [TBL] [Abstract][Full Text] [Related]  

  • 133.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 134.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 135.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 136.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 137.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 138.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 7.